Korean Journal of Radiology

The Korean Society of Radiology (대한영상의학회)
권호 표지
DOI QR코드

DOI QR Code

How to Treat Peripheral Arteriovenous Malformations

  • Ran Kim (Department of Radiology, Ewha Womans University Mokdong Hospital, College of Medicine, Ewha Womans University) ;
  • Young Soo Do (Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kwang Bo Park (Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Received : 2020.08.05
  • Accepted : 2020.08.15
  • Published : 2021.04.01
Download PDF
⟨ Previous Next ⟩

Abstract

Arteriovenous malformations (AVMs) are direct communications between primitive reticular networks of dysplastic vessels that have failed to mature into capillary vessels. Based on angiographic findings, peripheral AVMs can be classified into six types: type I, type IIa, type IIb, type IIc, type IIIa, and type IIIb. Treatment strategies vary with the types. Type I is treated by embolizing the fistula between the artery and the vein with coils. Type II (IIa, IIb, and IIc) AVM is treated as follows: first, reduce the blood flow velocity in the venous segment of the AVM with coils; second, perform ethanol embolotherapy of the residual shunts. Type IIIa is treated by transarterial catheterization of the feeding arteries and injection of diluted ethanol. Type IIIb is treated by transarterial or direct puncture approaches. A high concentration of ethanol is injected through the transarterial catheter or direct puncture needle. When the fistula is large, coil insertion is required to reduce the amount of ethanol. Type I and type II AVMs showed the best clinical results; type IIIb showed a satisfactory response rate. However, type IIIa showed the poorest response rate, either alone or in combination with other types. Clinical success can be achieved by using different treatment strategies for different angiographic AVM types.

Keywords

References

  1. Lee BB, Baumgartner I, Berlien HP, Bianchini G, Burrows P, Do YS, et al. Consensus document of the international union of angiology (IUA)-2013. Current concept on the management of arterio-venous malformations. Int Angiol 2013;32:9-36 
  2. Park HS, Do YS, Park KB, Kim DI, Kim YW, Kim MJ, et al. Ethanol embolotherapy of hand arteriovenous malformations. J Vasc Surg 2011;53:725-731 
  3. Do YS, Kim YW, Park KB, Kim DI, Park HS, Cho SK, et al. Endovascular treatment combined with embolosclerotherapy for pelvic arteriovenous malformations. J Vasc Surg 2012;55:465-471 
  4. Cho SK, Do YS, Shin SW, Kim DI, Kim YW, Park KB, et al. Arteriovenous malformations of the body and extremities: analysis of therapeutic outcomes and approaches according to a modified angiographic classification. J Endovasc Ther 2006;13:527-538 
  5. Flye MW, Jordan BP, Schwartz MZ. Management of congenital arteriovenous malformations. Surgery 1983;94:740-747 
  6. White RI, Pollak J, Persing J, Henderson KJ, Thompson JG, Burdge CM. Long-term outcome of embolotherapy and surgery for high-flow extremity arteriovenous malformations. J Vasc Interv Radiol 2000;11:1285-1295 
  7. Park KB, Do YS, Kim DI, Kim YW, Shin BS, Park HS, et al. Predictive factors for response of peripheral arteriovenous malformations to embolization therapy: analysis of clinical data and imaging findings. J Vasc Interv Radiol 2012;23:1478-1486 
  8. Ko SE, Do YS, Park KB, Kim DI, Heo SH, Bae SH, et al. Subclassification and treatment results of ethanol embolotherapy of type II arteriovenous malformations of the extremity and body. J Vasc Interv Radiol 2019;30:1443-1451 
  9. Park KB, Do YS, Kim DI, Kim YW, Park HS, Shin SW, et al. Endovascular teatment results and risk factors for complications of body and extremity arteriovenous malformations. J Vasc Surg 2019;69:1207-1218 
  10. Houdart E, Gobin YP, Casasco A, Aymard A, Herbreteau D, Merland JJ. A proposed angiographic classification of intracranial arteriovenous fistulae and malformations. Neuroradiology 1993;35:381-385 
  11. Yakes WF, Rossi P, Odink H. How I do it: arteriovenous malformation management. Cardiovasc Intervent Radiol 1996;19:65-71 
  12. Ko JS, Kim JA, Do YS, Kwon MA, Choi SJ, Gwak MS, et al. Prediction of the effect of injected ethanol on pulmonary arterial pressure during sclerotherapy of arteriovenous malformations: relationship with dose of ethanol. J Vasc Interv Radiol 2009;20:39-45 
  13. Shin BS, Do YS, Cho HS, Hahm TS, Kim CS, Sim WS, et al. Cardiovascular effects and predictability of cardiovascular collapse after repeated intravenous bolus injections of absolute ethanol in anesthetized pigs. J Vasc Interv Radiol 2010;21:1867-1872 
  14. Rao VR, Mandalam KR, Gupta AK, Kumar S, Joseph S. Dissolution of isobutyl 2-cyanoacrylate on long-term follow-up. AJNR Am J Neuroradiol 1989;10:135-141 
  15. Wohlgemuth WA, Muller-Wille R, Teusch VI, Dudeck O, Cahill AM, Alomari AI, et al. The retrograde transvenous push-through method: a novel treatment of peripheral arteriovenous malformations with dominant venous outflow. Cardiovasc Intervent Radiol 2015; 38:623-631 
  16. Bauer AM, Bain MD, Rasmussen PA. Onyx resorbtion with AVM recanalization after 4 complete AVM obliteration. Interv Neuroradiol 2015;21:351-356 
  17. Hyun D, Do YS, Park KB, Kim DI, Kim YW, Park HS, et al. Ethanol embolotherapy of foot arteriovenous malformations. J Vasc Surg 2013;58:1619-1626 
  18. Do YS, Park KB. Special consideration for intraosseous arteriovenous malformations. Semin Intervent Radiol 2017;34:272-279 
  19. Do YS, Park KB, Park HS, Cho SK, Shin SW, Moon JW, et al. Extremity arteriovenous malformations involving the bone: therapeutic outcomes of ethanol embolotherapy. J Vasc Interv Radiol 2010;21:807-816